Alteration of NMDA receptors in different excitatory synapses in the hippocampus of APP/PS1 transgenic miceRocio Alfaro Ruiz, Carolina Aguado, Alejandro Martín Belmonte et al.
Blood D-serine levels correlate with aging and dopaminergic treatment in Parkinson's diseaseIsar Yahyavi, Alberto Imarisio, Micol Avenali et al.
The effects of disease-associated mutations on the conformational dynamics of NMDA receptorsMark Dobrovolskii, Klevinda Fili, Vojtech Vyklicky, Ladislav Vyklicky
Extrasynaptic NMDARs activation by co-agonist glycine controls the occurrence of bursts in nigral dopamine neuronsSofian Ringlet, Laura Caldinelli, Laura Vandries et al.
Glycine receptors regulate striatal cholinergic interneurons and dopamine releaseSimon Bossi, Ioannis Mantas, Vasiliki Skara et al.
Hydroxynorketamine, but not ketamine, acts via α7 nicotinic acetylcholine receptor to control presynaptic function and gene expressionDebarpan Guhathakurta, Aneta Petrušková, Enes Yağız Akdaş et al.
Insights into the pharmacology of GluN3A receptors: Exploring the mechanism of action of selective inhibitors and their activity at native receptorsAnne-Kathrin Ludwig, Jadranka Hillebrecht, Sandra Fischer et al.
Neuroprotective effects induced by NR2A-CB1R and NR2B-CB1R complexes in Alzheimer's diseaseJoan Biel Rebassa Palou, Iu Raïch, Jaume Lillo et al.
NMDAR blockade impairs cognitive control necessary for evidence accumulation and short-term memoryAlexis Cerván, Tiffany Oña-Jodar, Genís Prat-Ortega et al.
The role of the GDG motif of the GluN2 subunit in the mechanism of NMDAR activationEni Tomovic, Viktor Kuchtiak, Jiri Černy, Ales Balik
The role of neocortical and hippocampal presynaptic NMDA receptors in the induction of spike timing-dependent long-term depressionMatthew Roxby, Ole Paulsen